表紙
市場調查報告書

全球全身麻醉劑市場:各分子類型、地區 - 市場規模,佔有率,預測,及機會分析(2019年∼2027年)

General Anesthesia Drugs Market, By Molecule Type and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 920730
出版日期 內容資訊 英文 190 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球全身麻醉劑市場:各分子類型、地區 - 市場規模,佔有率,預測,及機會分析(2019年∼2027年) General Anesthesia Drugs Market, By Molecule Type and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2019年12月26日內容資訊: 英文 190 Pages
簡介

本報告提供全球全身麻醉劑市場的相關調查,市場機會,產品的銷售,影響分析,成長及阻礙因素,各分子類型、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的、前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場範圍

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 各分子類型
    • 各地區
    • Coherent Opportunity Map (COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的焦點
  • 產品銷售
  • 法規方案
  • PEST分析
  • 合併和收購

第4章 市場分析:各分子類型

  • 簡介
  • PROPOFOL
  • SEVOFLURANE
  • DEXMEDETOMIDINE
  • DESFLURANE
  • REMIFENTANIL
  • Midazolam
  • 其他

第5章 市場分析:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第6章 競爭情形

  • 企業簡介
    • Baxter International Inc.
    • AstraZeneca
    • AbbVie Inc.
    • B. Braun Melsungen AG
    • Fresenius SE & Co. KGaA
    • Hospira Inc.

第7章 Section

  • 參照資料
  • 調查方法
  • 關於本公司
目錄

Title:
General Anesthesia Drugs Market, By Molecule Type (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

General anesthesia is a therapeutically induced condition of unconsciousness; that is, loss of protective reflexes, which results from the use of one or multiple general anesthetic agents. The drug is administered to allow performing the medical procedures which are unbearably painful for the patient. A range of medicines can be administered, the overall aim of which is to ensure unconsciousness, analgesia, and loss of reflexes of the ANS or autonomic nervous system. In some cases, general anesthetic drugs are used for paralyzing the skeletal muscles.

Key features of the study::

  • This report provides in-depth analysis of the General Anesthesia Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global General Anesthesia Drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Hospira Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global General Anesthesia Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global General Anesthesia Drugs market

Detailed Segmentation::

  • General Anesthesia Drugs Market, By Molecule Type:
    • Propofol
    • Sevoflurane
    • Dexmedetomidine
    • Desflurane
    • Remifentanil
    • Midazolam
    • Others
  • General Anesthesia Drugs Market, By Region:
    • North America
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Baxter International Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • AstraZeneca
    • AbbVie Inc.
    • B. Braun Melsungen AG
    • Fresenius SE & Co. KGaA
    • Hospira Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Molecule Type
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • Regulatory Scenario
  • PEST Analysis
  • Mergers and Acquisitions

4. Global General Anesthesia Drugs Market, By Molecule Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Propofol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Keratolytics
    • Moisturizers
    • Retinoids
    • SunScreens
    • Hair Removals
  • Sevoflurane
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Dexmedetomidine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Desflurane
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Remifentanil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Midazolam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

5. Global General Anesthesia Drugs Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

6. Competitive Landscape

  • Company Profiles
    • Baxter International Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • B. Braun Melsungen AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Fresenius SE & Co. KGaA
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hospira Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top